Who we areWe are a team of individuals and organisations with an interest in the improvement of peoples’ lives through the generation and sharing of knowledge. Our backgrounds vary from genomics science, to entreprenuership, data science, open source technology, citizen science, open science, science policy and beyond.
What we have doneWe came together as a team to generate a principled response to MBIE’s Call For Proposalsin 2016. Our aim was to expand the discussion around conducting genomics research in our specific national context. To do that, we crafted a concept business plan and spun up this hubzero instance at https://genomics.nz where that plan is published.
The discussion has expanded as has the team. Over the winter of 2017, we wrote and edited the constitution for the Genomics for Aotearoa New Zealand society collaboratively -- with enthusiasm, kindness and fellowship. Together, we launched the society on 1 November. It was incorporated on 7 November.
What we are doingOur council is getting to work. This includes getting the nuts and bolts of the society in place and reaching out to other aligned people and organisations so that we can work together for benefit of everyone. We are also expanding content on the hub web site and writing our first set of bioinformatics tools to be run through this site. Our membership site is ready for you to join GFANZ.
On 1 November 2017 the first GFANZ members and interested people gathered for the launch.
The first 36 GFANZ members are from 5 Universities, 4 Crown Research Institutes, and 3 Companies, as well as unaffiliated individuals. Importantly, GFANZ is for everyone in Aotearoa New Zealand, not only genomics scientists. Our first members reflect that. We welcome everyone interested in genomics and in supporting the objectives of the society.
Of all the areas of modern biology, none reach as far into our personal lives and into society as genomics does, be it for human, animal or plant health. The dramatic impacts, however, also mean that genomics must not be used in isolation, but that its applications need to carefully consider societal needs and limits. It is hard to think of a more lucid vision taking these facts into account than the one put forward by the Genomics for Aotearoa New Zealand consortium. Detlef Weigel ForMemRS